首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy of Dose Escalation of Tamsulosin for the Treatment of Lower Urinary Tract Symptoms
Authors:Jin Wook KIM  Mi Mi OH  Jeong Kyun YEO  Jae Hyun BAE  Kwan Joong JOO  Jong Bo CHOI  Hong Seok PARK  Hyung Jee KIM  Du Geon MOON  Jeong Gu LEE
Affiliation:1. Department of Urology, Korea University College of Medicine, Guro Hospital, Seoul, Korea;2. Department of Urology, Inje University, Seoul Paik Hospital, Seoul, Korea;3. Department of Urology, Korea University College of Medicine, Ansan Hospital, Ansan, Korea;4. Department of Urology, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea;5. Department of Urology, Ajou University College of Medicine, Suwon, Korea;6. Department of Urology, Dankook University College of Medicine, Seoul, Korea;7. Department of Urology, Korea University College of Medicine, Anam Hospital, Seoul, Korea
Abstract:Objectives: The aim of this study was to compare the efficacy of low (0.2 mg) and intermediate (0.4 mg) dose tamsulosin in treating lower urinary tract symptoms (LUTS). Methods: Patients were treated with low‐dose tamsulosin for an initial run‐in period of 12 weeks, then divided into two groups based on their clinical improvement. Patients were measured for objective parameters of peak flow rate and postvoid residual urine volume, as well as subjective symptom scores and perceived patient benefit of treatment. The items were then integrated as the LUTS Outcome Score to determine dose increase or maintenance. Overall outcome was determined at 36 weeks. Results: One hundred and seventy‐four patients were enrolled and started on 0.2 mg tamsulosin treatment. One hundred and fifty‐five patients completed the 36‐week study. Sixty patients required dose increase to 0.4 mg at the 12th week. Baseline characteristics showed that a patient who would benefit from 0.4 mg dosage had higher age, daytime frequency, and lower peak urine flow rate. Patients receiving both 0.2 and 0.04 mg both showed improved clinical outcome measures. Higher improvement was found in voiding component symptom scores and urine flow rate improvement in patients receiving an increased dose. Conclusion: Both low‐ and intermediate‐dose tamsulosin are effective treatment regimens. Increasing from low to intermediate dose should follow assessment of both objective and subjective improvements.
Keywords:adrenergic alpha‐antagonist  benign prostatic hyperplasia  drug therapy  tamsulosin
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号